documents: FDA-2020-D-1136-0081

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1136-0081 FDA FDA-2020-D-1136 Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID–19 Public Health Emergency; Withdrawal of Guidance Notice Withdrawal 2023-02-10T05:00:00Z 2023 2 2023-02-10T05:00:00Z   2023-02-10T15:41:04Z 2023-02809 0 0 0900006485653eb7

Links from other tables